4//SEC Filing
Inrig Jula 4
Accession 0001415889-25-000899
CIK 0001438533other
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 7:21 PM ET
Size
7.3 KB
Accession
0001415889-25-000899
Insider Transaction Report
Form 4
Inrig Jula
CHIEF MEDICAL OFFICER
Transactions
- Sale
Common Stock
2025-01-03$19.10/sh−2,066$39,461→ 59,883 total - Sale
Common Stock
2025-01-06$18.76/sh−440$8,254→ 59,443 total
Footnotes (2)
- [F1]Represents the number of shares required to be sold by the Reporting Person to cover the tax withholding obligation in connection with the settlement of vested restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the Reporting Person to fund this tax withholding obligation by completing a "sell to cover" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the Reporting Person.
- [F2]This sale was made pursuant to a written plan adopted on March 15, 2024, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended, and includes the sale of shares to cover the tax obligation that occurred upon the vesting of restricted stock units.
Documents
Issuer
Travere Therapeutics, Inc.
CIK 0001438533
Entity typeother
Related Parties
1- filerCIK 0001902368
Filing Metadata
- Form type
- 4
- Filed
- Jan 5, 7:00 PM ET
- Accepted
- Jan 6, 7:21 PM ET
- Size
- 7.3 KB